Determination of the Minimal Concentration of Antifibrinolytics Required to Inhibit t-PA-activated Fibrinolysis

NCT02352675 · clinicaltrials.gov ↗

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Congenital Heart Disease
Fibrinolysis
Rotational Thromboelastometry

Interventions

OTHER: Intraoperative Blood Sample

Sponsor

Boston Children's Hospital